NICE decision on Alzheimer’s Drugs to Benefit Thousands
The Alzheimer’s Research Trust has welcomed the NICE decision to extend the availability of Alzheimer’s drugs. Three drugs currently used for moderate Alzheimer’s will now be available to treat mild stages of the disease as well. As part of the latest guidance NICE used a new economic model and found the drugs to be cost-effective. [...]
